120 related articles for article (PubMed ID: 18177690)
21. Establishment of a cell line expressing recombinant factor VII and its subsequent conversion to active form FVIIa through hepsin by genetic engineering method.
Halabian R; Roudkenar MH; Esmaeili NS; Masroori N; Roushandeh AM; Najafabadi AJ
Vox Sang; 2009 May; 96(4):309-15. PubMed ID: 19175565
[TBL] [Abstract][Full Text] [Related]
22. Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.
Chang YJ; Hamaguchi N; Chang SC; Ruf W; Shen MC; Lin SW
Biochemistry; 1999 Aug; 38(34):10940-8. PubMed ID: 10460149
[TBL] [Abstract][Full Text] [Related]
23. High-level expression of functional recombinant human coagulation factor VII in insect cells.
Masroori N; Halabian R; Mohammadipour M; Roushandeh AM; Rouhbakhsh M; Najafabadi AJ; Fathabad ME; Salimi M; Shokrgozar MA; Roudkenar MH
Biotechnol Lett; 2010 Jun; 32(6):803-9. PubMed ID: 20213530
[TBL] [Abstract][Full Text] [Related]
24. Efficient expression of functional human coagulation factor IX in stably-transfected Drosophila melanogaster S2 cells; comparison with the mammalian CHO system.
Vatandoost J; Bos MH
Biotechnol Lett; 2016 Oct; 38(10):1691-8. PubMed ID: 27565667
[TBL] [Abstract][Full Text] [Related]
25. Vitamin K-dependent gamma-glutamylcarboxylation: an ancient posttranslational modification.
Bandyopadhyay PK
Vitam Horm; 2008; 78():157-84. PubMed ID: 18374194
[TBL] [Abstract][Full Text] [Related]
26. Absence of Vitamin K-Dependent γ-Carboxylation in Human Periostin Extracted from Fibrotic Lung or Secreted from a Cell Line Engineered to Optimize γ-Carboxylation.
Annis DS; Ma H; Balas DM; Kumfer KT; Sandbo N; Potts GK; Coon JJ; Mosher DF
PLoS One; 2015; 10(8):e0135374. PubMed ID: 26273833
[TBL] [Abstract][Full Text] [Related]
27. [Vitamin K epoxide reductase: Fresh blood for oral anticoagulant therapies].
Loriot MA; Beaune P
Rev Med Interne; 2006 Dec; 27(12):979-82. PubMed ID: 17070618
[TBL] [Abstract][Full Text] [Related]
28. Vitamin K-induced modification of coagulation phenotype in VKORC1 homozygous deficiency.
Marchetti G; Caruso P; Lunghi B; Pinotti M; Lapecorella M; Napolitano M; Canella A; Mariani G; Bernardi F
J Thromb Haemost; 2008 May; 6(5):797-803. PubMed ID: 18315553
[TBL] [Abstract][Full Text] [Related]
29. Expression of recombinant vitamin K-dependent proteins in mammalian cells: factors IX and VII.
Berkner KL
Methods Enzymol; 1993; 222():450-77. PubMed ID: 8412810
[No Abstract] [Full Text] [Related]
30. Cloning and expression of rat coagulation factor VII.
Seetharam S; Murphy K; Atkins C; Feuerstein G
Thromb Res; 2003 Feb; 109(4):225-31. PubMed ID: 12757778
[TBL] [Abstract][Full Text] [Related]
31. Recent findings in understanding the biological function of vitamin K.
Uotila L; Suttie JW
Med Biol; 1982 Feb; 60(1):16-24. PubMed ID: 6803084
[TBL] [Abstract][Full Text] [Related]
32. Severe factor VII deficiency caused by a novel mutation His348 to Gln in the catalytic domain.
Katsumi A; Matsushita T; Yamazaki T; Sugiura I; Kojima T; Saito H
Thromb Haemost; 2000 Feb; 83(2):239-43. PubMed ID: 10739380
[TBL] [Abstract][Full Text] [Related]
33. VKORC1 and the vitamin K cycle.
Garcia AA; Reitsma PH
Vitam Horm; 2008; 78():23-33. PubMed ID: 18374188
[TBL] [Abstract][Full Text] [Related]
34. The propeptides of human protein C, factor VII, and factor IX are exchangeable with regard to directing gamma-carboxylation of these proteins.
Geng JP; Castellino FJ
Thromb Haemost; 1996 Aug; 76(2):205-7. PubMed ID: 8865532
[TBL] [Abstract][Full Text] [Related]
35. The carboxylation efficiency of the vitamin K-dependent clotting factors: studies with factor IX.
Blostein M; Cuerquis J; Landry S; Galipeau J
Haemophilia; 2008 Sep; 14(5):1063-8. PubMed ID: 18680528
[TBL] [Abstract][Full Text] [Related]
36. Genotypes of vitamin K epoxide reductase, gamma-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients.
Kimura R; Miyashita K; Kokubo Y; Akaiwa Y; Otsubo R; Nagatsuka K; Otsuki T; Okayama A; Minematsu K; Naritomi H; Honda S; Tomoike H; Miyata T
Thromb Res; 2007; 120(2):181-6. PubMed ID: 17049586
[TBL] [Abstract][Full Text] [Related]
37. The vitamin K cycle.
Oldenburg J; Marinova M; Müller-Reible C; Watzka M
Vitam Horm; 2008; 78():35-62. PubMed ID: 18374189
[TBL] [Abstract][Full Text] [Related]
38. Production of coagulation factor VII in human cell lines Sk-Hep-1 and HKB-11.
Corrêa de Freitas MC; Bomfim AS; Mizukami A; Picanço-Castro V; Swiech K; Covas DT
Protein Expr Purif; 2017 Sep; 137():26-33. PubMed ID: 28651975
[TBL] [Abstract][Full Text] [Related]
39. mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
Yoshimura M; Ikeda H; Tabakoff B
Mol Pharmacol; 1996 Jul; 50(1):43-51. PubMed ID: 8700117
[TBL] [Abstract][Full Text] [Related]
40. HEK293 Cells Overexpressing Nuclear Factor E2-Related Factor-2 Improve Expression of Recombinant Coagulation Factor VII.
Abbasi-Malati Z; Amiri F; Mohammadipour M; Roudkenar MH
Mol Biotechnol; 2019 May; 61(5):317-324. PubMed ID: 30790232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
